Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consensi for Hypertension and Renal/Vascular Function
NCT02979197Phase 3Completed
- Sponsor
- Purple Biotech Ltd.
- Start
- Nov 2016
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Concensi in hypertension (HTN), sponsored by Purple Biotech Ltd. Started Nov 2016; status: completed.
02
Drugs
Concensi
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02979197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979197.